Sheaff Brock Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-366
| Closed | -$231K | – | 550 |
|
|
2021
Q4 | $231K | Buy |
+366
| New | +$231K | 0.02% | 445 |
|
|
2020
Q3 | – | Sell |
-390
| Closed | -$243K | – | 483 |
|
|
2020
Q2 | $243K | Buy |
+390
| New | +$243K | 0.02% | 342 |
|
|
2017
Q4 | – | Sell |
-490
| Closed | -$219K | – | 564 |
|
|
2017
Q3 | $219K | Sell |
490
-150
| -23% | -$67K | 0.03% | 453 |
|
|
2017
Q2 | $314K | Sell |
640
-110
| -15% | -$54K | 0.04% | 375 |
|
|
2017
Q1 | $291K | Buy |
750
+10
| +1% | +$3.88K | 0.04% | 403 |
|
|
2016
Q4 | $272K | Sell |
740
-280
| -27% | -$103K | 0.03% | 437 |
|
|
2016
Q3 | $410K | Buy |
1,020
+35
| +4% | +$14.1K | 0.05% | 298 |
|
|
2016
Q2 | $344K | Hold |
985
| – | – | 0.04% | 343 |
|
|
2016
Q1 | $355K | Buy |
985
+150
| +18% | +$54.1K | 0.04% | 348 |
|
|
2015
Q4 | $453K | Buy |
+835
| New | +$453K | 0.05% | 332 |
|